Related Experiment Video
Updated: Apr 1, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Biomarkers of primary open-angle glaucoma
Paul A Knepper1, John R Samples2, Beatrice Yjt Yue3
1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor, Chicago, IL 60612, USA ; Department of Ophthalmology, Northwestern University Medical School, 150 East Huron, Suite 1000, Chicago, IL 60611, USA.
Primary open-angle glaucoma (POAG) is a leading cause of blindness. Researchers identified extracellular matrix and immune biomarkers as key indicators for developing a POAG diagnostic signature.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of blindness globally, affecting 45 million people.
- It is a neuronal disease of the optic nerve, often linked to elevated intraocular pressure.
- Current understanding of POAG etiology remains incomplete.
Purpose of the Study:
- To elucidate potential etiologic factors in POAG by cataloging known biomarkers.
- To propose a theoretical model for POAG pathogenesis involving specific molecular pathways.
- To identify promising biomarkers for a diagnostic signature.
Main Methods:
- Cataloged biomarkers from aqueous humor, trabecular meshwork, optic nerve, and blood.
- Classified biomarkers into four categories: extracellular matrix (ECM), cell signaling, aging/stress, and immunity-related changes.
- Developed a theoretical model of signaling pathways, including ECM, cell signaling, and innate immune response via Toll-like receptor 4 activation.
Main Results:
- Identified extracellular matrix (ECM) and innate immune biomarkers as significant.
- Proposed a theoretical model linking ECM, cell signaling, and innate immunity in POAG pathogenesis.
- Highlighted Toll-like receptor 4 as a potential key mediator.
Conclusions:
- Extracellular matrix and innate immune biomarkers are strong candidates for a 'POAG biomarker signature'.
- Further research is crucial to pinpoint POAG causes.
- Developing a biomarker signature could lead to new treatments for intraocular pressure regulation and neuroprotection.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

